Takeda Rips Cert. Order's 'Whale Of Assumption' At 9th Circ. <https://www.law360.com/insurance/articles/2260961?nl_pk=59612751-8689-4b1e-9154-1edd7f62646f&utm_source=newsletter&utm_medium=email&utm_campaign=insurance&utm_content=2024-11-15&read_main=1&nlsidx=0&nlaidx=3> By Dorothy Atkins Takeda Pharmaceutical urged the Ninth Circuit on Thursday to reverse a ruling certifying a class of third-party payors who allege Takeda and Eli Lilly & Co. hid their anti-diabetes drug's bladder-cancer risks, arguing the lower court erroneously made a "whale of an assumption" that 56.7% of prescriptions wouldn't have been written with disclosures. Read full article » <https://www.law360.com/insurance/articles/2260961?nl_pk=59612751-8689-4b1e-9154-1edd7f62646f&utm_source=newsletter&utm_medium=email&utm_campaign=insurance&utm_content=2024-11-15&read_more=1&nlsidx=0&nlaidx=3> | Save to favorites » <https://www.law360.com/insurance/articles/2260961?nl_pk=59612751-8689-4b1e-9154-1edd7f62646f&utm_source=newsletter&utm_medium=email&utm_campaign=insurance&utm_content=2024-11-15&read_later=1&nlsidx=0&nlaidx=3>